Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.22.01794
PubMed Identifier: 36888930
Publication URI: http://europepmc.org/abstract/MED/36888930
Type: Journal Article/Review
Volume: 41
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 15
ISSN: 0732-183X